Cargando…
The Potential of Thyroid Hormone Therapy in Severe COVID-19: Rationale and Preliminary Evidence
Tissue hypoxia is one of the main pathophysiologic mechanisms in sepsis and particularly in COVID-19. Microvascular dysfunction, endothelialitis and alterations in red blood cell hemorheology are all implicated in severe COVID-19 hypoxia and multiorgan dysfunction. Tissue hypoxia results in tissue i...
Autores principales: | Mourouzis, Iordanis, Apostolaki, Vassiliki, Trikas, Athanasios, Kokkinos, Leonidas, Alexandrou, Natassa, Avdikou, Maria, Giannoulopoulou, Myrto, Vassi, Aimilia, Tseti, Ioulia, Pantos, Constantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265958/ https://www.ncbi.nlm.nih.gov/pubmed/35805716 http://dx.doi.org/10.3390/ijerph19138063 |
Ejemplares similares
-
Effects of Thyroid Hormone on Tissue Hypoxia: Relevance to Sepsis Therapy
por: Lourbopoulos, Athanasios I., et al.
Publicado: (2021) -
Triiodothyronine for the treatment of critically ill patients with COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial
por: Pantos, Constantinos, et al.
Publicado: (2020) -
Triiodothyronine prevents tissue hypoxia in experimental sepsis: potential therapeutic implications
por: Mourouzis, Iordanis S., et al.
Publicado: (2021) -
Use of triiodothyronine to treat critically ill COVID-19 patients: a new clinical trial
por: Pantos, Constantinos, et al.
Publicado: (2020) -
Thyroid Hormone and Tissue Repair: New Tricks for an Old Hormone?
por: Mourouzis, Iordanis, et al.
Publicado: (2013)